Annual Congress Vienna 2003

Saturday, 27.09.2003
Sunday, 28.09.2003
Monday, 29.09.2003
Tuesday, 30.09.2003
Wednesday, 01.10.2003

Citations should be made in the following way: Authors. Title. Eur Respir J 2003; 22: Suppl. 45, abstract number.

Material from 2003:

3196 Abstracts
374 Slide presentations

Material from 2003: Show

Advanced lung cancer treatment

Oral Presentation
Chairs: J. Vansteenkiste (Leuven, Belgium), G. Buccheri (Cuneo, Italy)

Download all media

Gemcitabine (G) or vinorelbine (V)? What's the best drug in combination with a platinium-derivative for the treatment of locally advanced and metastatic non small cell lung cancer (NSCLC)? A 6 years retrospective study M. J. Melo, P. Barradas, M. Cristovao, A. Costa, A. Alves (Lisbon, Portugal)
*Gemcitabine plus vinorelbine (GV) or paclitaxel (GT) versus* gemcitabine (G) or paclitaxel (T) alone in elderly or unfit nonsmall cell lung cancer (NSCLC) patients. SICOG 9909 phase III trial** A. Bianco, G. Frasci, P. Comella, G. De Cataldis, F. Del Gaizo, V. Lorusso, N. Panza, G. Mazzarella, D. Muci, F. Buzzi, A. Gambardella, S. A. Marsico, G. Comella (Naples, Italy)
Low dosage chemotherapy, with carboplatin (CBDCA) and vinorelbine (VNR), in advanced nonsmall cell lung cancer (NSCLC) in patients with low performance status A. Caprioli, G. Bozzola, A. M. Nava, G. Rinaldi, G. F. Tassi (Brescia, Italy)
Preliminary analysis of a multicenter phase III trial comparing docetaxel (D) versus docetaxel/cisplatin (DC) in patients with inoperable advanced and metastatic non small cell lung cancer (NSCLC) E. Dimopoulou, A. Agelidou, I. Giozos, Z. Stefanaki, F. Vlastos, E. Tsaroucha, V. Georgoulias (Heraklion, Greece)
Second-line weekly paclitaxel in advanced nonsmall cell lung cancer (NSCLC) G. Buccheri, D. Ferrigno, M. C. Giordano (Cuneo, Italy)
Paclitaxel/carboplatin vs paclitaxel/carboplatin/etoposide as first line treatment in SCLC. A phase III randomized trial K. P. Zarogoulidis, A. Xafenias, A. Xatzopoulou, A. Papagiannis, F. Zoglopitis, E. Fahandidou, T. N. Kontakiotis (Thessaloniki, Greece)
The protective effects of ASA on free radical metabolism in cisplatin induced nephrotoxicity in experimental models B. Ulubas, B. Cimen, D. Apa, E. Saritas, N. Muslu, A. Kanik, O. Cimen (Mersin, Turkey)
Response shift in individual quality of life in patients with lung cancer E. Mannion, D. Waldron, T. Azher, J. J. Gilmartin (Galway, Ireland)